Can the prophylactic use of raloxifene, a selective estrogen-receptor modulator, prevent bone mineral loss and fractures in women with diagnosed osteoporosis or vertebral fractures?
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tamoxifen;Meyler's Side Effects of Drugs;2016
2. DRUGS USED IN CANCER CHEMOTHERAPY;Meyler's Side Effects of Drugs in Cancer and Immunology;2010
3. Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics;British Journal of Clinical Pharmacology;2009-04
4. SEX HORMONES AND RELATED DRUGS;Meyler's Side Effects of Endocrine and Metabolic Drugs;2009
5. Tamoxifen;Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions;2006